アイゼンメンジャー症候群:治療薬のグローバル治験動向(2014年下半期)...市場調査レポートについてご紹介

【英文タイトル】Eisenmenger Syndrome Global Clinical Trials Review, H2, 2014

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Eisenmenger Syndrome 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Eisenmenger Syndrome to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Eisenmenger Syndrome to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Subjects Recruited Over a Period of Time 25
Clinical Trials by Sponsor Type 26
Prominent Sponsors 27
Top Companies Participating in Eisenmenger Syndrome Therapeutics Clinical Trials 28
Prominent Drugs 29
Clinical Trial Profiles 30
Clinical Trial Overview of Top Companies 30
Actelion Ltd 30
Clinical Trial Overview of Actelion Ltd 30
Mednax 31
Clinical Trial Overview of Mednax 31
Clinical Trial Overview of Top Institutes / Government 32
Masih Daneshvari Hospital 32
Clinical Trial Overview of Masih Daneshvari Hospital 32
Govind Ballabh Pant Hospital 33
Clinical Trial Overview of Govind Ballabh Pant Hospital 33
Second University of Naples 34
Clinical Trial Overview of Second University of Naples 34
Gachon University Gil Hospital 35
Clinical Trial Overview of Gachon University Gil Hospital 35
University of Heidelberg 36
Clinical Trial Overview of University of Heidelberg 36
University of California, Los Angeles 37
Clinical Trial Overview of University of California, Los Angeles 37
Imperial College London 38
Clinical Trial Overview of Imperial College London 38
Competence Network for Congenital Heart Defects 39
Clinical Trial Overview of Competence Network for Congenital Heart Defects 39
Rigshospitalet 40
Clinical Trial Overview of Rigshospitalet 40
Department of Defence, Australia 41
Clinical Trial Overview of Department of Defence, Australia 41
Five Key Clinical Profiles 42
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81


【レポート販売概要】

■ タイトル:アイゼンメンジャー症候群:治療薬のグローバル治験動向(2014年下半期)
■ 英文:Eisenmenger Syndrome Global Clinical Trials Review, H2, 2014
■ 発行日:2014年8月30日
■ 調査会社:GlobalData
■ 商品コード:GDHC2326CTIDB
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。